{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:30:17Z","timestamp":1792639817740,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.9807","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T21:57:04Z","timestamp":1622152624000},"page":"e219807","source":"Crossref","is-referenced-by-count":67,"title":["Comparison of Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant in Refractory or Relapsed Peripheral T-Cell Lymphoma"],"prefix":"10.1001","volume":"4","author":[{"given":"Jun","family":"Du","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinle","family":"Han","sequence":"additional","affiliation":[{"name":"Shenzhen PKU-HKUST Medical Center, Shenzhen, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Binjiang College of Nanjing University of Information Science & Technology, Jiangsu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoufang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Gannan Medical University, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"3","key":"zoi210300r1","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1016\/j.bbmt.2019.12.499","article-title":"Long term outcomes of patients with aggressive T-cell non-Hodgkin lymphoma undergoing allogeneic stem cell transplantation: retrospective results from single center.","volume":"26","author":"Salhotra","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"zoi210300r2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"16","key":"zoi210300r3","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"zoi210300r4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.critrevonc.2015.12.016","article-title":"Panoptic clinical review of the current and future treatment of relapsed\/refractory T-cell lymphomas: peripheral T-cell lymphomas.","volume":"99","author":"Zinzani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"zoi210300r5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41409-019-0734-7","article-title":"Autologous hematopoietic stem cell transplantation for relapsed\/refractory systemic anaplastic large cell lymphoma. a retrospective analysis of the lymphoma working party (LWP) of the EBMT.","volume":"55","author":"Domingo-Dom\u00e8nech","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"zoi210300r6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3322\/caac.v70.1","article-title":"The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management.","volume":"70","author":"Marchi","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"zoi210300r7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11912-020-00902-1","article-title":"Therapy of peripheral T cell lymphoma: focus on nodal subtypes.","volume":"22","author":"Allen","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"zoi210300r8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28129","article-title":"The effect of graft-versus-host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults.","volume":"67","author":"Mitsui","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"zoi210300r9"},{"issue":"9","key":"zoi210300r10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument.","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"issue":"1","key":"zoi210300r11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-020-00892-4","article-title":"Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC).","volume":"13","author":"Mamez","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"4","key":"zoi210300r12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/ejh.v105.4","article-title":"Improved outcomes with allogeneic compared with autologous stem cell transplantation in aggressive T-cell lymphoma.","volume":"105","author":"McIlroy","year":"2020","journal-title":"Eur J Haematol"},{"issue":"98","key":"zoi210300r13","article-title":"Outcomes of myeloablative peripheral blood stem cell transplantation for non-complete remission patients with relapsed\/refractory peripheral T cell lymphomas.","volume":"5","author":"Zhenyang","year":"2019","journal-title":"Ann Hematol"},{"issue":"6","key":"zoi210300r14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41409-018-0360-9","article-title":"Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.","volume":"54","author":"Wulf","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"48","key":"zoi210300r15","first-page":"3786","article-title":"Evaluation of clinical outcomes of allogeneic hematopoietic stem cell transplantation for relapsed\/refractory peripheral T-cell lymphoma with chemoresistance.","volume":"99","author":"Wang","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"8","key":"zoi210300r16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.bbmt.2017.04.021","article-title":"Outcome of allogeneic and autologous hematopoietic cell transplantation for high-risk peripheral T cell lymphomas: a retrospective analysis from a Chinese center.","volume":"23","author":"Huang","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"zoi210300r17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/leu.2014.79","article-title":"Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.","volume":"28","author":"Corradini","year":"2014","journal-title":"Leukemia"},{"issue":"25","key":"zoi210300r18","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1200\/JCO.2012.46.0188","article-title":"Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.","volume":"31","author":"Smith","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi210300r19","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.bbmt.2013.07.003","article-title":"Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin\u2019s lymphoma.","volume":"19","author":"Czajczynska","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"zoi210300r20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/leu.2011.240","article-title":"Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed\/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.","volume":"26","author":"Dodero","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"zoi210300r21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3109\/10428194.2011.574754","article-title":"Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.","volume":"52","author":"Zain","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"zoi210300r22","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/annonc\/mdq698","article-title":"A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides\/Sezary syndrome.","volume":"22","author":"Jacobsen","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"zoi210300r23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2141.2010.08210.x","article-title":"Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.","volume":"150","author":"Shustov","year":"2010","journal-title":"Br J Haematol"},{"issue":"14","key":"zoi210300r24","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Francaise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire.","volume":"26","author":"Le Gouill","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi210300r25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","article-title":"Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma.","volume":"36","author":"Wulf","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"zoi210300r26","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi210300r27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12185-018-2560-x","article-title":"Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.","volume":"109","author":"Yamasaki","year":"2019","journal-title":"Int J Hematol"},{"issue":"10","key":"zoi210300r28","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00432-019-02999-9","article-title":"The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.","volume":"145","author":"Roerden","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"zoi210300r29","first-page":"952","article-title":"Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas.","volume":"37","author":"Wang","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"25","key":"zoi210300r30","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"zoi210300r31","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1093\/annonc\/mdp211","article-title":"High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).","volume":"20","author":"Nickelsen","year":"2009","journal-title":"Ann Oncol"},{"issue":"1","key":"zoi210300r32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi210300r33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","article-title":"Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.","volume":"14","author":"Chen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"zoi210300r34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.bmt.1705712","article-title":"Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.","volume":"40","author":"Smith","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"zoi210300r35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00277-007-0254-1","article-title":"High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.","volume":"86","author":"Kim","year":"2007","journal-title":"Ann Hematol"},{"issue":"2","key":"zoi210300r36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bjh.2006.134.issue-2","article-title":"Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.","volume":"134","author":"Kewalramani","year":"2006","journal-title":"Br J Haematol"},{"issue":"120","key":"zoi210300r37","article-title":"Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.","volume":"6","author":"Kevin","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"zoi210300r38","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","article-title":"High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.","volume":"14","author":"Rodr\u00edguez","year":"2003","journal-title":"Ann Oncol"},{"issue":"7","key":"zoi210300r39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.","volume":"27","author":"Blystad","year":"01","journal-title":"Bone Marrow Transplant"},{"key":"zoi210300r40","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020008825","article-title":"A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL.","author":"Schmitz","year":"2020","journal-title":"Blood"},{"issue":"24","key":"zoi210300r41","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1200\/JCO.2008.20.4628","article-title":"Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.","volume":"27","author":"Kyriakou","year":"2009","journal-title":"J Clin Oncol"},{"key":"zoi210300r42","author":"Shmitz","year":"2019"},{"issue":"2","key":"zoi210300r43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000358579","article-title":"Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis.","volume":"133","author":"Wei","year":"2015","journal-title":"Acta Haematol"},{"issue":"4","key":"zoi210300r44","article-title":"Strategy for assessing new drug value in orphan diseases: an international case match control analysis of the PROPEL study.","volume":"2","author":"O\u2019Connor","year":"2018","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"10","key":"zoi210300r45","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/S2352-3026(20)30207-6","article-title":"The peripheral T-cell lymphomas: an unusual path to cure.","volume":"7","author":"Ma","year":"2020","journal-title":"Lancet Haematol"},{"key":"zoi210300r46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12688\/f1000research","article-title":"Treatment approaches in relapsed or refractory peripheral T-cell lymphomas.","volume":"9","author":"Foster","year":"2020","journal-title":"F1000Res"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2780407\/du_2021_oi_210300_1621458932.3355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:12:31Z","timestamp":1699067551000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2780407"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.9807","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}